STENOCARE deadlines for its ongoing Unit Right Issue: Last day for subscription for shares at DKK 4.58 each is Thursday June 8
STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER: STENO
STENOCARE A/S (“Stenocare”) is currently offering its shareholders and new investors to join its public issue with a formal last day on Thursday, June 8, 2023. investors should be aware that Nordnet has defined Tuesday June 6 as the deadline to subscribe in their system.
Note: Monday, June 5, 2023 is a bank holiday in Denmark (Grundlovsdag), and Tuesday June 6 is a bank holiday in Sweden (Nationaldag). Nordnet is open for online subscription both days.
Clarification and recommendation to act now: Stenocare provides this clarification in response to several questions received about the last day of subscription. The last day at which the issuing bank (Danske Bank) must receive any subscriptions – with or without rights - is Thursday, June 8, 2023, but certain banks – such as Nordnet – have decided to reserve some time for their expedition of customer orders to Danske Bank. Customers of Danske Bank can submit their subscriptions from clients all the way to June 8, 2023, but all interested subscribers must subscribe asap and follow the instructions and deadlines of their own banks.
Last day of trading in rights: In any case, the formal deadline for purchase of unit rights – which is the instrument that can be purchased by anyone that does not have (enough) rights from an existing holding of shares – is June 6, 2023. Also, subscription can be made without the backing of rights. This is done digitally through Nordnet/Avanza or by filling in and sending the special form for subscription without rights to the bank: https://stenocare.com/wp-content/uploads/2023/05/SUBSCRIPTION-FORM-without-use-of-Unit-Rights-ENG-.pdf
About the issue: The ongoing public share issue is for Units, at a price per unit of DKK 9.16, including 2 shares (at DKK 4.58 each) and 2 free warrants. The unit rights issue amounts to up to 10,7mDKK and is backed by pre-subscription from management, board and others, as well as guarantors, amounting to a total of 86% of the issue and lenders that have committed to convert into Units. In total, this corresponds to more than 100% of the issue, but in order to make room for public subscription if needed, the conversion of debt will take place in a separate directed issue, in addition to the public issue. Links:
https://www.nordnet.dk/dk/kampagner/emission/stenocare
https://stenocare.com/share-issue-2023/
Minimum requirement: Please notice that according to Nasdaq policy there is a minimum subscription of Euro 500 for investors without Unit Rights – which is approx. equal to 407 Units. However, investors that like to subscribe for less than 407 Units can purchase Unit Rights for the desired number of Units (for each Unit the investor need to purchase 10 Unit Rights). The price of a Unit Right (ticker: “STENO UR”) is available from the bank or from Nasdaq STENO UR, Stenocare A/S UR, (DK0062493458) - Nasdaq (nasdaqomxnordic.com)
For additional information please contact:
Thomas Skovlund Schnegelsberg, CEO, Phone: +45 31770060, E-mail: presse@stenocare.com
or Sadjad Hassani, Associate – Gemstone Capital, Phone: +45 3322 0700, E-mail: sh@gemstonecapital.com
About STENOCARE A/S
Stenocare was founded in 2017 with the purpose of supplying prescription-based medical cannabis to patients in Denmark and internationally. The company was first to receive the Danish Medicines Agency's permission to import, distribute as well as cultivate and produce medical cannabis. Stenocare sources its products from a number of carefully selected international high-quality suppliers and operates a unique, indoor state-of-the-art cultivation facility in Denmark, that has multiple levels of redundancy to safeguard quality and uniformity in a pesticide free production process www.stenocare.com